Learn more about whether Travere Therapeutics, Inc. or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Learn more about whether Twist Bioscience Corporation or Zymeworks Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Cidara Therapeutics skyrockets 1,165% after positive CD388 data and Merck's acquisition bid. Read why CDTX stock is a Hold.

Seers Technology, D&D Pharmatech, OliX, ABL Bio. Among the top 10 stocks with the highest stock price increases this year, ...

Daiichi Sankyo Company ($DSKYF) announced an update on their ongoing clinical study. Study OverviewThis study, officially titled “KEYMAKER-U01 ...

Each year, the internet gives birth to a new lexicon, one that's as fast-moving and unpredictable as the online trends that ...

Clinical data presented at ASCO 2025 showed an objective response rate (ORR) of 63% among all patients, with a median progression-free survival (PFS) of 7.7 months. Responses were seen across ...

Radionuclide drug conjugates (RDCs) have emerged as transformative agents that integrate diagnosis and therapy into a single clinical workflow. By ...

The U.S. childhood immunization schedule, the grid of colored bars pediatricians share with parents, recommends a set of vaccines given from birth through adolescence to prevent a range of serious ...

Unlike many of the state’s other required vaccines, Florida’s Health Department can drop these four required shots without legislative approval.

PeptiDream Inc., a public Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter “PeptiDream”)(Tokyo: 4587), announced the achievement of a preclinical development milestone in ...